# Buprenorphine Transdermal Patches Pharmacokinetic Study

> **NCT03975010** · PHASE1 · UNKNOWN · sponsor: **Mundipharma (China) Pharmaceutical Co. Ltd** · enrollment: 45 (estimated)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** Buprenorphine Transdermal Patch

## Key facts

- **NCT ID:** NCT03975010
- **Lead sponsor:** Mundipharma (China) Pharmaceutical Co. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-13
- **Primary completion:** 2020-03-31
- **Final completion:** 2020-03-31
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2019-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03975010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03975010, "Buprenorphine Transdermal Patches Pharmacokinetic Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03975010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*